🇺🇸 FDA
Patent

US 11904052

Methods for ameliorating infusion reactions

granted A61KA61K31/192A61K45/06

Quick answer

US patent 11904052 (Methods for ameliorating infusion reactions) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARBUTUS BIOPHARMA CORPORATION
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/192, A61K45/06, A61K47/10, A61K47/24